Home
>
National Drug Code (NDC)
>
Prefera OB plus DHA
Prefera OB plus DHA - 68220-089-05 - (FOLIC ACID, Heme Iron Polypeptide, IRON DEXTRAN, Potassium Iodide, Zinc Oxide, Selenium, CUPRIC SULFATE, CHOLECALCIFEROL, THIAMINE MONONITRATE, ALPHA-TOCOPHEROL SUCCINATE, D-, RIBOFLAVIN, NIACINAMIDE,)
Drug Information of Prefera OB plus DHA
| Product NDC: | 68220-089 |
| Proprietary Name: | Prefera OB plus DHA |
| Non Proprietary Name: | FOLIC ACID, Heme Iron Polypeptide, IRON DEXTRAN, Potassium Iodide, Zinc Oxide, Selenium, CUPRIC SULFATE, CHOLECALCIFEROL, THIAMINE MONONITRATE, ALPHA-TOCOPHEROL SUCCINATE, D-, RIBOFLAVIN, NIACINAMIDE, |
| Active Ingredient(s): | 10; 30; 10; 400; .8; 12; 1; 6; 22; 17; 175; 50; 1.6; 65; 1.5; 15 [iU]/1; ug/1; mg/1; [iU]/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1 & nbsp; FOLIC ACID, Heme Iron Polypeptide, IRON DEXTRAN, Potassium Iodide, Zinc Oxide, Selenium, CUPRIC SULFATE, CHOLECALCIFEROL, THIAMINE MONONITRATE, ALPHA-TOCOPHEROL SUCCINATE, D-, RIBOFLAVIN, NIACINAMIDE, |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Prefera OB plus DHA
| Product NDC: | 68220-089 |
| Labeler Name: | Alaven Pharmaceutical LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20090401 |
Package Information of Prefera OB plus DHA
| Package NDC: | 68220-089-05 |
| Package Description: | 5 TABLET in 1 BLISTER PACK (68220-089-05) |
NDC Information of Prefera OB plus DHA
| NDC Code | 68220-089-05 |
| Proprietary Name | Prefera OB plus DHA |
| Package Description | 5 TABLET in 1 BLISTER PACK (68220-089-05) |
| Product NDC | 68220-089 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | FOLIC ACID, Heme Iron Polypeptide, IRON DEXTRAN, Potassium Iodide, Zinc Oxide, Selenium, CUPRIC SULFATE, CHOLECALCIFEROL, THIAMINE MONONITRATE, ALPHA-TOCOPHEROL SUCCINATE, D-, RIBOFLAVIN, NIACINAMIDE, |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090401 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Alaven Pharmaceutical LLC |
| Substance Name | ALPHA-TOCOPHEROL SUCCINATE, D-; BIOTIN; CALCIUM PANTOTHENATE; CHOLECALCIFEROL; CUPRIC SULFATE; CYANOCOBALAMIN; FOLIC ACID; HEME IRON POLYPEPTIDE; IRON DEXTRAN; NIACINAMIDE; POTASSIUM IODIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN; SELENIUM; THIAMINE MONONITRATE; ZINC OXIDE |
| Strength Number | 10; 30; 10; 400; .8; 12; 1; 6; 22; 17; 175; 50; 1.6; 65; 1.5; 15 |
| Strength Unit | [iU]/1; ug/1; mg/1; [iU]/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1 |
| Pharmaceutical Classes | Copper [Chemical/Ingredient],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE],Vitamin D [Chemical/Ingredient],Vitamin D [EPC],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC] |
